Inotropic agents in the treatment of cardiogenic shock

Pharmacol Ther. 1983;22(1):53-79. doi: 10.1016/0163-7258(83)90052-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Cardiac Output, Low / complications
  • Cardiac Tamponade / complications
  • Cardiotonic Agents / therapeutic use*
  • Catecholamines / therapeutic use*
  • Digitalis
  • Dobutamine / therapeutic use*
  • Dopamine / therapeutic use*
  • Glucagon / therapeutic use
  • Humans
  • Isoproterenol / therapeutic use*
  • Metaraminol / therapeutic use
  • Methoxamine / therapeutic use
  • Myocardial Infarction / complications*
  • Norepinephrine / therapeutic use
  • Phenylephrine / therapeutic use
  • Plants, Medicinal
  • Plants, Toxic
  • Pulmonary Embolism / complications
  • Shock, Cardiogenic / drug therapy*

Substances

  • Cardiotonic Agents
  • Catecholamines
  • Phenylephrine
  • Dobutamine
  • Metaraminol
  • Glucagon
  • Methoxamine
  • Isoproterenol
  • Dopamine
  • Norepinephrine